Skin Carcinoma Clinical Trial
Official title:
Self-Monitoring and Readiness Texting Project (SMART)
This pilot clinical trial studies how well Self Monitoring And Readiness Texting (SMART) project works in sun exposure and protection behaviors. Measuring how behavior tracking and individually tailored messages affect risk behaviors in patients with skin cancer may help doctors plan the best prevention plan and decrease national melanoma incidence and mortality.
PRIMARY OBJECTIVES:
I. To test the effects of a behavior tracking and individually-tailored daily text message
intervention on sun protection and exposure behaviors and to see if these techniques will be
most effective in conjunction or separately.
SECONDARY OBJECTIVES:
I. To examine mediators in the effects of the intervention on safe sun behaviors, based on
Fishbein?s Integrative Model.
OUTLINE: Patients are randomized to 1 of 4 study arms.
ARM I (SELF-MONITORING): Patients complete tanning and sun protection usage entries daily for
14 days.
ARM II (TEXT MESSAGES): Patients receive individualized text messages based on baseline
assessment of tanning motives (appearance, enjoyment, social) daily for 14 days.
ARM III (COMBINED GROUP): Patients complete tanning and sun protection usage entries and also
receive individualized text messages daily for 14 days.
ARM IV (CONTROL GROUP): Patients complete study assessments.
After completion of study, patients are followed up at 2 weeks.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04358276 -
Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study
|
N/A | |
| Completed |
NCT01242618 -
Tissue Engineered Nasal Cartilage for Reconstruction of the Alar Lobule
|
Phase 1 | |
| Not yet recruiting |
NCT06167096 -
Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery
|
N/A | |
| Recruiting |
NCT03699995 -
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma
|
N/A | |
| Completed |
NCT04456140 -
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
|
Phase 1 | |
| Terminated |
NCT03630601 -
Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy Volunteers
|
N/A | |
| Recruiting |
NCT03543969 -
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
|
Early Phase 1 | |
| Completed |
NCT00783965 -
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
|
Phase 2 | |
| Recruiting |
NCT04475640 -
Cancer Genetic Testing in Ethnic Populations
|
N/A | |
| Active, not recruiting |
NCT02465060 -
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
|
Phase 2 | |
| Completed |
NCT02417948 -
Improving Sun-Protective Behaviors and Skin Self-Examinations Among African Americans
|
N/A | |
| Completed |
NCT03290989 -
Itch and Pain Characteristics in Skin Carcinomas
|
N/A |